CASEY JAMISON: Open Payments
NPI 1043614233 · CROSSROADS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 33 payments from 7 companies in 2025. Trend: 2023 $401 · 2024 $552 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $252 |
| Novo Nordisk Inc | 7 | $139 |
| PFIZER INC. | 3 | $75 |
| Astellas Pharma US Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: UBRELVY, NURTEC ODT, Wegovy, Ozempic, VRAYLAR, QULIPTA, Veozah, Symbravo.
Industry payments across TX — which companies pay providers there.
